ORBIS MEDICINES

HQ - Copenhagen

Summary

Orbis Medicines is a biotechnology company focused on pioneering a new era for oral macrocycle drug discovery.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 98 M

Avg. Deal Size£ 49 M

Market Context

Senior Management